MBX Biosciences, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | $4.3M | $84.2M | $30.5M |
| FY2024 | $11.1M | $268.5M | $49.4M |
| FY2025 | $15.9M | $385.1M | $75.3M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | $4.3M | $84.2M | $30.5M |
| FY2024 | $11.1M | $268.5M | $49.4M |
| FY2025 | $15.9M | $385.1M | $75.3M |